PharmaPoint: Hepatitis C Virus – Brazil Drug Forecast and Market Analysis to 2022
PharmaPoint: Hepatitis C Virus – Brazil Drug Forecast and Market Analysis to 2022
Filed under: drug rehab treatment ny
Currently, drug combinations containing pegylated interferon (e.g., Roche's Pegasys and Merck's PegIntron) and ribavirin (e.g., Roche's Copegus and Merck's Rebetol) are used to treat HCV infection. Patients infected with HCV genotype 1 can also have a …
Read more on PR Newswire (press release)
Twelve Steps to Danger: How Alcoholics Anonymous Can Be a Playground for …
Filed under: drug rehab treatment ny
“We do not discriminate against any prospective AA member, even if he or she comes to us under pressure from a court, an employer, or any other agency,” the public information officer at New York's central office wrote in a June email. “We cannot …
Read more on ProPublica
US HOT STOCKS: Stec, Vanguard Health, Keynote Systems, Healthways
Filed under: drug rehab treatment ny
Allergan Inc.'s (AGN, $ 83.76, -$ 8.94, -9.64%) treatment for chronic dry eye disease–Restasis–could face generic competition sooner than expected, leading to downgrades from Deutsche Bank and Leerink Swann. Sales estimates for Restasis, … Credit …
Read more on Wall Street Journal
PharmaPoint: Hepatitis C Virus – China Drug Forecast and Market Analysis to 2022
Filed under: drug rehab treatment ny
Currently, drug combinations containing pegylated interferon (e.g., Roche's Pegasys and Merck's PegIntron) and ribavirin (e.g., Roche's Copegus and Merck's Rebetol) are used to treat HCV infection. Patients infected with HCV genotype 1 can also have a …
Read more on PR Newswire (press release)